Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.